Skip to main content
Full access
Letter to the Editor
Published Online: 1 March 1999

Persistent Delirium Tremens

Publication: American Journal of Psychiatry
To the Editor: We read with great interest “Persistent Delirium Following Cessation of Heavy Alcohol Consumption: Diagnostic and Treatment Implications” by David Hersh, M.D., et al. (1). Although the medical workup of the case is generally impeccable, there are a few shortcomings that we would like to comment on:
1. There was only one application of breath alcohol level on admission. It is desirable to repeat the test several times in the first 24 hours of detoxification. We have been surprised more than once to note that the blood alcohol level may initially rise in subsequent readings before it declines.
2. There was no mention of urine drug screen for this case. Alcoholism in isolation is a rare condition today. Most alcoholics will often abuse one or more additional substances. While cocaine and marijuana may not have any impact on the alcohol withdrawal syndrome, the sedative hypnotics or anxiolytics can significantly alter the course of withdrawal symptoms. There are occasions when patients fail to report the coexistence of such substances with alcohol consumption.
3. In their differential diagnosis, the authors discuss many of the relevant causes of protracted delirium tremens. We believe, in this case, the treatment strategy may have contributed to the clinical picture of a persistent delirium tremens.
The patient was an elderly man whose metabolism of many drugs, including benzodiazepines, had significantly diminished. The patient was considered a moderate-to-severe risk for alcohol withdrawal syndrome. Treatment with chlor­diazepoxide, 50 mg every 4 hours, began. This was an extremely high dose for a 71-year-old man. The authors note that the first 3 hospital days were relatively uneventful. Nevertheless, the patient received 350 mg of chlordiaze­poxide on each of the first 2 days of treatment and 250 mg on the third day. Hence, a 71-year-old man received 950 mg of a long half-life benzodiazepine with many active metabolites over 72 hours.
The delirium persisted despite the high doses of a benzodiazepine. Once the delirium was established, the authors noted that the addition of higher doses of chlordiazepoxide or lorazepam produced either extreme sedation or a worsening of the confusional state. On the eighth hospital day, the patient was still receiving benzodiazepines when oral haloperidol was begun. Therefore, large doses of benzodiazepines initially may lead to delirium in an elderly man.
Attributing elevated pulse and blood pressure solely to alcohol withdrawal syndrome, when other withdrawal syndromes (such as from β blocker, clonidine, a sedative hypnotic, or an anxiolytic) could have also contributed, may ultimately cause secondary delirium. Susceptible individuals may be prone to develop delirium by withdrawal (undermedication with benzodiazepines) or toxicity (overmedication with benzodiazepines). Therefore, in addition to the urine drug screen, obtaining a careful drug history is critical to the successful management of a complicated alcohol detoxification. Use of a short-acting benzodiazepine is another suggestion that would limit the complicating factors of overmedication with benzodiazepines.

References

1.
Hersh D, Kranzler HR, Meyer RE: Persistent delirium following cessation of heavy alcohol consumption: diagnostic and treatment implications. Am J Psychiatry 1997; 154:846–851

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 496
PubMed: 10080576

History

Published online: 1 March 1999
Published in print: March 1999

Authors

Affiliations

HOWARD J. ILIVICKY, M.D
MARYLOUIS FRIEDBERGER, P.A.C.
Philadelphia, Pa.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share